\-\ Texto\\:\\ \ \(0\)\
\-\ blood\\ sugar\\ 400\ \(0\)\
\-\ csf\\ negative\ \(0\)\
\-\ no\\ fever\ \(12\)\
\-\ no\\ facial\\ or\\ ocular\\ lesions\ \(0\)\
\-\ physical\\ therapy\\,\\ insulin\\,\\ and\\ anti\\ seizure\\ medication\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ frontal\\ lobe\\ leptomeningeal\\ enhancement\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ brain\\ edema\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ calcification\\ on\\ ct\\ scan\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ angiogram\\ \\(not\\ shown\\)\\ was\\ negative\ \(0\)\
\-\ leptomeningeal\\ \\ angiomatosis\ \(1\)\
\-\ \\â\\€\\¢\\ meningitis\ \(2\)\
\-\ \\â\\€\\¢\\ leptomeningeal\\ tumor\\ \ \(0\)\
\-\ \\â\\€\\¢\\ sturge\\-weber\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ herpes\\ encephalitis\ \(0\)\
\-\ 11\\ year\\ old\\ boy\\,\\ with\\ known\\ type\\ i\\ diabetes\\,\\ presents\\ to\\ er\\ with\\ a\\ seizure\\.\\ \\ has\\ a\\ persistent\\ left\\ sided\\ weakness\\ following\\ seizure\\.\ \(0\)\
\-\ since\\ the\\ boy\\ had\\ no\\ obvious\\ skin\\ or\\ other\\ finding\\ consistent\\ with\\ sturge\\ weber\\ and\\ an\\ unexplained\\ persistent\\ left\\ hemiplegia\\ meningitis\\ or\\ vasculiltis\\ was\\ suspected\\.\\ \\ \ \(0\)\
\-\ consequently\\ he\\ had\\ a\\ negative\\ cerebral\\ angiogram\\ followed\\ by\\ leptomeningeal\\ biopsy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.4376718450451989\ \(0\)\
\-\ sturge\\:\\ 0\\.2659769099531766\ \(0\)\
\-\ seizure\\:\\ 0\\.2583352662972592\ \(0\)\
\-\ weber\\:\\ 0\\.2365544888204016\ \(0\)\
\-\ meningitis\\:\\ 0\\.19494541410193758\ \(0\)\
\-\ negative\\:\\ 0\\.19219824197482094\ \(0\)\
\-\ angiogram\\:\\ 0\\.1859221261414407\ \(0\)\
\-\ no\\:\\ 0\\.16825868597266197\ \(0\)\
\-\ vasculiltis\\:\\ 0\\.1654930408324703\ \(0\)\
\-\ persistent\\:\\ 0\\.15946553343690387\ \(0\)\
\-\ boy\\:\\ 0\\.14157951562891133\ \(0\)\
\-\ angiomatosis\\:\\ 0\\.13820733997973866\ \(0\)\
\-\ unexplained\\:\\ 0\\.13820733997973866\ \(0\)\
\-\ sugar\\:\\ 0\\.13153638782784727\ \(0\)\
\-\ insulin\\:\\ 0\\.13153638782784727\ \(0\)\
\-\ consequently\\:\\ 0\\.13153638782784727\ \(0\)\
\-\ 400\\:\\ 0\\.12283637835154282\ \(0\)\
\-\ hemiplegia\\:\\ 0\\.11967340656931309\ \(0\)\
\-\ herpes\\:\\ 0\\.11577103773721274\ \(0\)\
\-\ or\\:\\ 0\\.10800045931957027\ \(0\)\
\-\ ocular\\:\\ 0\\.10604185100195762\ \(0\)\
\-\ had\\:\\ 0\\.10311881570389474\ \(0\)\
\-\ encephalitis\\:\\ 0\\.10290628278200493\ \(0\)\
\-\ obvious\\:\\ 0\\.09623533063011352\ \(0\)\
\-\ medication\\:\\ 0\\.09564691727241444\ \(0\)\
\-\ anti\\:\\ 0\\.0954549455891734\ \(0\)\
\-\ diabetes\\:\\ 0\\.09452442599662482\ \(0\)\
\-\ facial\\:\\ 0\\.08533016942793759\ \(0\)\
\-\ suspected\\:\\ 0\\.08479181672484833\ \(0\)\
\-\ csf\\:\\ 0\\.08176942521818291\ \(0\)\
\-\ shown\\:\\ 0\\.08022089898654905\ \(0\)\
\-\ 11\\:\\ 0\\.0774716088280614\ \(0\)\
\-\ er\\:\\ 0\\.0774008829888579\ \(0\)\
\-\ skin\\:\\ 0\\.076982222375251\ \(0\)\
\-\ weakness\\:\\ 0\\.07552485001963553\ \(0\)\
\-\ since\\:\\ 0\\.07496083086746495\ \(0\)\
\-\ calcification\\:\\ 0\\.07388282139927699\ \(0\)\
\-\ biopsy\\:\\ 0\\.0725384172061663\ \(0\)\
\-\ was\\:\\ 0\\.07213022112646926\ \(0\)\
\-\ cerebral\\:\\ 0\\.07169449040226733\ \(0\)\
\-\ left\\:\\ 0\\.07060112655011432\ \(0\)\
\-\ fever\\:\\ 0\\.07016330775622846\ \(0\)\
\-\ followed\\:\\ 0\\.06988131521645109\ \(0\)\
\-\ type\\:\\ 0\\.06942085509665248\ \(0\)\
\-\ finding\\:\\ 0\\.06802132535728588\ \(0\)\
\-\ known\\:\\ 0\\.06699844143535381\ \(0\)\
\-\ frontal\\:\\ 0\\.06660490854651295\ \(0\)\
\-\ sided\\:\\ 0\\.06656602074002946\ \(0\)\
\-\ brain\\:\\ 0\\.0645114949348701\ \(0\)\
\-\ syndrome\\:\\ 0\\.06238634058112083\ \(0\)\
\-\ following\\:\\ 0\\.062080411665388364\ \(0\)\
\-\ edema\\:\\ 0\\.06171997951567666\ \(0\)\
\-\ scan\\:\\ 0\\.06139575853408602\ \(0\)\
\-\ he\\:\\ 0\\.06127928201981175\ \(0\)\
\-\ with\\:\\ 0\\.06079023453342971\ \(0\)\
\-\ blood\\:\\ 0\\.06009941040822362\ \(0\)\
\-\ lobe\\:\\ 0\\.05980267114891405\ \(0\)\
\-\ enhancement\\:\\ 0\\.059563443663179415\ \(0\)\
\-\ therapy\\:\\ 0\\.05945812461684826\ \(0\)\
\-\ lesions\\:\\ 0\\.05943189011512829\ \(0\)\
\-\ physical\\:\\ 0\\.05611126349639024\ \(0\)\
\-\ consistent\\:\\ 0\\.05611126349639024\ \(0\)\
\-\ tumor\\:\\ 0\\.054128004051038375\ \(0\)\
\-\ other\\:\\ 0\\.05374077153066579\ \(0\)\
\-\ presents\\:\\ 0\\.04978102419597826\ \(0\)\
\-\ has\\:\\ 0\\.047268360623796475\ \(0\)\
\-\ by\\:\\ 0\\.04394520100359524\ \(0\)\
\-\ and\\:\\ 0\\.042767298974498894\ \(0\)\
\-\ not\\:\\ 0\\.04085292191810496\ \(0\)\
\-\ an\\:\\ 0\\.03957183770124387\ \(0\)\
\-\ ct\\:\\ 0\\.039397234286230216\ \(0\)\
\-\ right\\:\\ 0\\.034309144044159995\ \(0\)\
\-\ year\\:\\ 0\\.03189165357836248\ \(0\)\
\-\ on\\:\\ 0\\.031253868034440475\ \(0\)\
\-\ old\\:\\ 0\\.03062702700507845\ \(0\)\
\-\ to\\:\\ 0\\.025870733617838468\ \(0\)\
\-\ the\\:\\ 0\\.020648757338412767\ \(0\)\
